NVIDIA launched Nemotron for Science, enhancing scientific research with models, datasets, and tools for specialized discovery agents.
Quiver AI Summary
NVIDIA has launched the NVIDIA Nemotron for Science, which integrates the Nemotron 3.5 Super VL model, an open chemistry dataset, and post-training recipes to assist researchers in developing specialized agents for scientific discovery. Key features include the LitmusBench v0.2, a dataset containing nearly 50,000 questions for evaluating chemistry reasoning in language models, and the ability for scientists to post-train models to enhance their performance on specific tasks such as chemistry experiments and protein design. Prominent research institutions, including Argonne National Laboratory, are leveraging this technology to expedite scientific advancements, utilizing it in applications ranging from drug discovery to material synthesis. The models and datasets are currently available on Hugging Face, facilitating broader access to cutting-edge AI tools for researchers.
Potential Positives
- NVIDIA Nemotron for Science provides researchers with an advanced toolset, including the Nemotron 3.5 Super VL model and a comprehensive open chemistry dataset, enabling significant advancements in scientific discovery.
- Leading global research institutions, such as the U.S. Department of Energy’s Argonne National Laboratory, are adopting NVIDIA’s technologies to expedite research in critical fields, demonstrating strong market demand and credibility for NVIDIA's offerings.
- The integration of NVIDIA Nemotron into the workflows of prominent life sciences companies highlights its practical applications in areas like drug discovery and materials science, potentially leading to groundbreaking developments in these sectors.
- Significant post-training improvements in model accuracy for various scientific applications suggest that NVIDIA's technology is effectively enhancing research outcomes and setting new benchmarks in performance.
Potential Negatives
- While the advanced capabilities of the NVIDIA Nemotron 3.5 Super VL and its applications are highlighted, the press release is heavily reliant on forward-looking statements that may not guarantee future performance, risking investor trust and highlighting uncertainties in product development and market acceptance.
- The mention of dependencies on third parties for manufacturing and potential risks associated with competition and technological developments raises concerns about the company's control over its product quality and market positioning.
- The statement that many products and features remain in various stages and will be offered on a "when-and-if-available" basis suggests a lack of immediate availability and could lead to customer dissatisfaction or loss of business opportunities.
FAQ
What is NVIDIA Nemotron for Science?
NVIDIA Nemotron for Science integrates the Nemotron 3.5 Super VL model with scientific datasets and training recipes to aid research.
How does LitmusBench v0.2 support scientific research?
LitmusBench v0.2 provides nearly 50,000 questions for evaluating language models specifically for chemistry reasoning tasks.
Who is using NVIDIA Nemotron in their research?
Leading institutions like Argonne National Laboratory and companies like Lila Sciences are utilizing Nemotron for scientific discovery and AI applications.
What advantages does post-training offer for Nemotron models?
Post-training allows researchers to adapt models for specialized tasks, improving their performance in scientific experimentation and discovering new materials.
Where can I access NVIDIA Nemotron resources?
NVIDIA Nemotron 3.5 Super VL and the LitmusBench v0.2 dataset are available on Hugging Face for research and application development.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$NVDA Insider Trading Activity
$NVDA insiders have traded $NVDA stock on the open market 32 times in the past 6 months. Of those trades, 0 have been purchases and 32 have been sales.
Here’s a breakdown of recent trading of $NVDA stock by insiders over the last 6 months:
- MARK A STEVENS has made 0 purchases and 21 sales selling 6,121,740 shares for an estimated $1,353,730,171.
- TIMOTHY S. TETER (EVP, General Counsel and Sec) has made 0 purchases and 6 sales selling 60,460 shares for an estimated $13,323,047.
- COLETTE KRESS (EVP & Chief Financial Officer) has made 0 purchases and 3 sales selling 34,918 shares for an estimated $7,648,632.
- STEPHEN C NEAL sold 15,500 shares for an estimated $3,343,863
- JOHN DABIRI sold 625 shares for an estimated $133,750
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$NVDA Revenue
$NVDA had revenues of $96.2B in Q2 2027. This is an increase of 105.85% from the same period in the prior year.
You can track NVDA financials on Quiver Quantitative's NVDA stock page.
You can access data on NVDA stock through the Quiver Quantitative API.
$NVDA Congressional Stock Trading
Members of Congress have traded $NVDA stock 24 times in the past 6 months. Of those trades, 11 have been purchases and 13 have been sales.
Here’s a breakdown of recent trading of $NVDA stock by members of Congress over the last 6 months:
- REPRESENTATIVE MARIA ELVIRA SALAZAR has traded it 2 times. They made 2 purchases worth up to $30,000 on 10/23 and 0 sales.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 1 purchase worth up to $15,000 on 07/17 and 2 sales worth up to $30,000 on 10/20, 08/18.
- REPRESENTATIVE PETE SESSIONS sold up to $50,000 on 10/02.
- REPRESENTATIVE CLEO FIELDS has traded it 6 times. They made 6 purchases worth up to $90,000 on 10/01, 06/26 and 0 sales.
- REPRESENTATIVE DANIEL MEUSER has traded it 3 times. They made 0 purchases and 3 sales worth up to $45,000 on 09/25, 08/31, 05/27.
- REPRESENTATIVE JOHN MCGUIRE purchased up to $15,000 on 08/18.
- SENATOR SHELDON WHITEHOUSE has traded it 3 times. They made 0 purchases and 3 sales worth up to $115,000 on 08/13, 06/30.
- SENATOR CORY A. BOOKER sold up to $50,000 on 08/11.
- REPRESENTATIVE SAM LICCARDO sold up to $50,000 on 07/21.
- REPRESENTATIVE DAN NEWHOUSE sold up to $15,000 on 07/10.
- REPRESENTATIVE MICHAEL A. RULLI purchased up to $15,000 on 06/25.
- REPRESENTATIVE MATTHEW VAN EPPS sold up to $15,000 on 06/16.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
$NVDA Hedge Fund Activity
We have seen 3,189 institutional investors add shares of $NVDA stock to their portfolio, and 2,579 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM removed 6,972,960,239 shares (-99.5%) from their portfolio in Q3 2026, for an estimated $1,592,484,659,382
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. removed 160,214,733 shares (-100.0%) from their portfolio in Q3 2026, for an estimated $36,589,840,722
- FMR LLC removed 93,243,728 shares (-9.1%) from their portfolio in Q3 2026, for an estimated $21,295,002,600
- SG AMERICAS SECURITIES, LLC added 62,298,007 shares (+inf%) to their portfolio in Q2 2026, for an estimated $12,465,208,220
- CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM removed 22,264,066 shares (-32.6%) from their portfolio in Q2 2026, for an estimated $4,454,816,965
- DEKABANK DEUTSCHE GIROZENTRALE added 20,798,082 shares (+648.5%) to their portfolio in Q3 2026, for an estimated $4,749,865,967
- CAPITAL WORLD INVESTORS removed 20,306,821 shares (-18.6%) from their portfolio in Q3 2026, for an estimated $4,637,671,779
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$NVDA Analyst Ratings
Wall Street analysts have issued reports on $NVDA in the last several months. We have seen 21 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- TD Cowen issued a "Buy" rating on 11/16/2026
- Mizuho issued a "Outperform" rating on 11/16/2026
- Barclays issued a "Overweight" rating on 11/13/2026
- Rosenblatt issued a "Buy" rating on 11/13/2026
- Needham issued a "Buy" rating on 11/12/2026
- Cantor Fitzgerald issued a "Overweight" rating on 11/12/2026
- RBC Capital issued a "Outperform" rating on 11/12/2026
To track analyst ratings and price targets for $NVDA, check out Quiver Quantitative's $NVDA forecast page.
$NVDA Price Targets
Multiple analysts have issued price targets for $NVDA recently. We have seen 33 analysts offer price targets for $NVDA in the last 6 months, with a median target of $250.0.
Here are some recent targets:
- Joshua Buchalter from TD Cowen set a target price of $200.0 on 11/16/2026
- Vijay Rakesh from Mizuho set a target price of $220.0 on 11/16/2026
- William Stein from Truist Securities set a target price of $174.0 on 11/13/2026
- Tom O'Malley from Barclays set a target price of $210.0 on 11/13/2026
- Kevin Cassidy from Rosenblatt set a target price of $300.0 on 11/13/2026
- Atif Malik from Citigroup set a target price of $225.0 on 11/12/2026
- James Schneider from Goldman Sachs set a target price of $220.0 on 11/12/2026
Full Release
News Summary:
- NVIDIA Nemotron for Science brings together the Nemotron 3.5 Super VL model, scientific evaluations, a new open chemistry dataset and recipes to help researchers build domain-specific science agents.
- LitmusBench v0.2 supports both evaluation and post-training for chemistry reasoning, helping researchers assess model capabilities and adapt models to scientific tasks.
- NVIDIA DGX Spark and data center infrastructure take Nemotron 3.5 Super VL from researchers’ desktops to supercomputing centers, enabling secure scientific workflows on infrastructure organizations control.
- Leading global research institutions, including the U.S. Department of Energy’s Argonne National Laboratory, are using Nemotron to build agents to speed scientific discovery.
CHICAGO, Nov. 16, 2026 (GLOBE NEWSWIRE) -- SC26 - NVIDIA today introduced NVIDIA Nemotron for Science, bringing together scientific applications of its NVIDIA Nemotron™ 3.5 Super VL open model, a new open chemistry dataset and post-training recipes to help researchers build specialized agents for scientific discovery.
Built on Nemotron 3.5 Super VL, Nemotron for Science helps researchers develop agents that reason through scientific problems and put specialized research tools to work. With post-training, scientists can adapt the model to specialized tasks such as conducting experiments for chemistry, protein design and more.
Part of Nemotron for Science, LitmusBench v0.2 is a new open dataset with nearly 50,000 questions for training and evaluating language models on chemistry reasoning. Drawing on molecular properties and experimental drug discovery data, it helps researchers improve models’ ability to predict how molecules behave, including their solubility and how the human body processes them.
Life sciences companies Lila Sciences, Terray Therapeutics and Therna are using and customizing NVIDIA Nemotron 3.5 Super VL for science applications. Use cases include extracting chemical knowledge, planning experiments and designing therapeutics and laboratory protocols. Major research centers like Argonne and Jülich Supercomputing Centre are integrating it into their drug and scientific discovery AI agents.
“Accelerated computing is transforming how scientists tackle the world’s most complex challenges,” said Ian Buck, vice president of hyperscale and high-performance computing at NVIDIA. “Nemotron for Science gives researchers open models, scientific data and post-training recipes to build specialized agents that reason through scientific problems and use CUDA-X accelerated tools to turn ideas into discoveries.”
Post-Training Nemotron Open Models for Scientific Discovery
Researchers can post-train Nemotron open models with domain-specific data to improve performance on specialized scientific tasks. They can integrate the resulting model into agent workflows that interpret scientific information, generate code and call computational tools. These workflows can use
NVIDIA CUDA-X
™ accelerated tools to perform scientific computation.
Terray Therapeutics post-trained Nemotron to extract reactants, products and reaction conditions from scientific diagrams, surpassing previously published results on two benchmarks. On the RxnScribe test, it recovered about 76% of annotated reactions under the benchmark’s matching criteria, helping turn published chemistry discoveries into structured data for synthesis planning and scientific agents.
Lila Sciences used Nemotron to design execution-ready laboratory protocols for its automated labs, matching frontier-level performance without requiring additional fine-tuning. Post-training with laboratory feedback nearly doubled the model’s accuracy for making quantum dots — nanoscale crystals used in screens and solar panels — to 61%, exceeding GPT-6 Astra’s 54% at 10-20x lower inference cost. These gains help agents and materials scientists translate desired material properties into synthesis recipes, advancing the discovery of new materials.
Therna collaborated with NVIDIA to post-train Nemotron for agentic mRNA therapeutic design, nearly doubling accuracy in predicting protein-expression ranges over frontier models. Scientists preferred its explanations over those from the base model in 96% of comparisons. These gains could help scientists tailor mRNA designs for the desired protein production in specific cell types as they scale to human use.
Researchers Speed Science With Nemotron Models and Datasets
Leading research institutions are using NVIDIA Nemotron models and datasets to advance scientific discovery at every scale, from individual researchers’ desktops to labs and supercomputing centers.
By helping researchers rapidly design and evaluate novel molecules across the periodic table, the work has the potential to open new pathways for applications in critical materials and minerals, national security and cancer treatment.
Argonne is integrating Nemotron into its StructBioReasoner multi-agent system to design and evaluate protein-based therapeutic candidates for treatment of cancer and other diseases.
KTH Royal Institute of Technology has built an AI agent on Nemotron that repairs broken GROMACS molecular dynamics setups on its own. In one overnight run on a single NVIDIA DGX Spark ™ system, the agent fixed 81% of test cases with reasoning enabled, and every fix was checked independently by GROMACS itself.
RIKEN has made NVIDIA Nemotron, including Nemotron 3.5 Super VL, available on its RIKYU AI supercomputing platform through RiVault, its inference gateway, enabling researchers to access the models for scientific research and the development of accelerated applications.
Availability
NVIDIA Nemotron 3.5 Super VL
and the
LitmusBench v0.2
chemistry dataset are available now on Hugging Face. The Nemotron 3.5 Super VL model was also optimized to run locally on a 128GB
NVIDIA DGX Spark system
.
Learn more in this technical blog on post-training NVIDIA Nemotron to increase accuracy across scientific domains.
About NVIDIA
NVIDIA
(NASDAQ: NVDA) is the world leader in AI and accelerated computing.
For further information, contact:
Lexi Mariash
Corporate Communications
NVIDIA Corporation
[email protected]
Certain statements in this press release including, but not limited to, statements as to: accelerated computing transforming how scientists tackle the world’s most complex challenges; Nemotron for Science giving researchers open models, scientific data and post-training recipes to build specialized agents that reason through scientific problems and use CUDA-X accelerated tools to turn ideas into discoveries; expectations with respect to growth, performance, availability, and benefits of NVIDIA’s products, services and technologies, and related trends and drivers; expectations with respect to NVIDIA’s third party arrangements, including with its collaborators and partners; expectations with respect to technology developments, and related trends and drivers; projected market growth and trends; expectations with respect to AI and related industries; and other statements that are not historical facts are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to the “safe harbor” created by those sections based on management’s beliefs and assumptions and on information currently available to management and are subject to risks and uncertainties that could cause results to be materially different than expectations. Important factors that could cause actual results to differ materially include: global economic and political conditions; NVIDIA’s reliance on third parties to manufacture, assemble, package and test NVIDIA’s products; the impact of technological development and competition; development of new products and technologies or enhancements to NVIDIA’s existing product and technologies; market acceptance of NVIDIA’s products or NVIDIA’s partners’ products; design, manufacturing or software defects; changes in consumer preferences or demands; changes in industry standards and interfaces; unexpected loss of performance of NVIDIA’s products or technologies when integrated into systems; and changes in applicable laws and regulations, as well as other factors detailed from time to time in the most recent reports NVIDIA files with the Securities and Exchange Commission, or SEC, including, but not limited to, its annual report on Form 10-K and quarterly reports on Form 10-Q. Copies of reports filed with the SEC are posted on the company’s website and are available from NVIDIA without charge. These forward-looking statements are not guarantees of future performance and speak only as of the date hereof, and, except as required by law, NVIDIA disclaims any obligation to update these forward-looking statements to reflect future events or circumstances.
Many of the products and features described herein remain in various stages and will be offered on a when-and-if-available basis. The statements above are not intended to be, and should not be interpreted as a commitment, promise, or legal obligation, and the development, release, and timing of any features or functionalities described for our products is subject to change and remains at the sole discretion of NVIDIA. NVIDIA will have no liability for failure to deliver or delay in the delivery of any of the products, features or functions set forth herein.
© 2026 NVIDIA Corporation. All rights reserved. NVIDIA, the NVIDIA logo, and other NVIDIA product and service names are trademarks and/or registered trademarks of NVIDIA Corporation in the U.S. and other countries and regions. Other company, product, and service names may be trademarks of the respective companies with which they are associated.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/d53cd8d8-0dec-4949-8fc0-2813db89a91a